340 related articles for article (PubMed ID: 31751658)
1. An effective live attenuated vaccine against Streptococcus agalactiae infection in farmed Nile tilapia (Oreochromis niloticus).
Zhang D; Gao Y; Li Q; Ke X; Liu Z; Lu M; Shi C
Fish Shellfish Immunol; 2020 Mar; 98():853-859. PubMed ID: 31751658
[TBL] [Abstract][Full Text] [Related]
2. Immune response and protective efficacy of two new adjuvants, Montanide™ ISA 763B VG and Montanide™ GEL02, administered with a Streptococcus agalactiae ghost vaccine in Nile tilapia (Oreochromis niloticus).
Wangkaghart E; Deville S; Wang B; Srisapoome P; Wang T; Secombes CJ
Fish Shellfish Immunol; 2021 Sep; 116():19-29. PubMed ID: 34153428
[TBL] [Abstract][Full Text] [Related]
3. Cross-immunity in Nile tilapia vaccinated with Streptococcus agalactiae and Streptococcus iniae vaccines.
Wang Q; Fu T; Li X; Luo Q; Huang J; Sun Y; Wang X
Fish Shellfish Immunol; 2020 Feb; 97():382-389. PubMed ID: 31841691
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of live attenuated vaccine derived from the Streptococcus agalactiae on the immune responses of Oreochromis niloticus.
Laith AA; Abdullah MA; Nurhafizah WWI; Hussein HA; Aya J; Effendy AWM; Najiah M
Fish Shellfish Immunol; 2019 Jul; 90():235-243. PubMed ID: 31009810
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy of MONTANIDE™ GR01, a new adjuvant for feed-based vaccines, on the immune response and protection against Streptococcus agalactiae in oral vaccinated Nile tilapia (Oreochromis niloticus) under laboratory and on-farm conditions.
Pholchamat S; Vialle R; Luang-In V; Phadee P; Wang B; Wang T; Secombes CJ; Wangkahart E
Fish Shellfish Immunol; 2024 Jun; 149():109567. PubMed ID: 38641215
[TBL] [Abstract][Full Text] [Related]
6. Characterization of novel antigenic vaccine candidates for nile tilapia (Oreochromis niloticus) against Streptococcus agalactiae infection.
Ma Y; Hao L; Liang Z; Ma J; Ke H; Kang H; Yang H; Wu J; Feng G; Liu Z
Fish Shellfish Immunol; 2020 Oct; 105():405-414. PubMed ID: 32712231
[TBL] [Abstract][Full Text] [Related]
7. Development of live attenuated Streptococcus agalactiae as potential vaccines by selecting for resistance to sparfloxacin.
Pridgeon JW; Klesius PH
Vaccine; 2013 May; 31(24):2705-12. PubMed ID: 23583891
[TBL] [Abstract][Full Text] [Related]
8. Recombinant lactococcal-based oral vaccine for protection against Streptococcus agalactiae infections in tilapia (Oreochromis niloticus).
Wong KY; Megat Mazhar Khair MH; Song AAL; Masarudin MJ; Loh JY; Chong CM; Beardall J; Teo MYM; In LLA
Fish Shellfish Immunol; 2024 Jun; 149():109572. PubMed ID: 38636739
[TBL] [Abstract][Full Text] [Related]
9. Construction of Streptococcus agalactiae sialic acid mutant and evaluation of its potential as a live attenuated vaccine in Nile tilapia (Oreochromis niloticus).
Hao J; Wang S; Wei Z; Zhang Q; Wu Z; Lin Y; Yang J; Zhang J; Zhang D; Li A
J Appl Microbiol; 2022 Oct; 133(4):2403-2416. PubMed ID: 35801502
[TBL] [Abstract][Full Text] [Related]
10. Development of Streptococcus agalactiae vaccines for tilapia.
Liu G; Zhu J; Chen K; Gao T; Yao H; Liu Y; Zhang W; Lu C
Dis Aquat Organ; 2016 Dec; 122(2):163-170. PubMed ID: 28000606
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity in Oreochromis niloticus vaccinated with sonicated antigens against streptococcosis.
Marcusso PF; da Silva Claudiano G; Yunis-Aguinaga J; de Almeida Marinho-Neto F; Eto SF; Fernandes DC; Rosolem MC; Salvador R; Engracia de Moraes JR; Ruas de Moraes F
Fish Shellfish Immunol; 2021 Aug; 115():134-141. PubMed ID: 34098067
[TBL] [Abstract][Full Text] [Related]
12. Generation of a novel Streptococcus agalactiae ghost vaccine and examination of its immunogenicity against virulent challenge in tilapia.
Wang Q; Wang X; Wang X; Feng R; Luo Q; Huang J
Fish Shellfish Immunol; 2018 Oct; 81():49-56. PubMed ID: 29969706
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Streptococcus agalactiae (group B) vaccine in tilapia (Oreochromis niloticus) by intraperitoneal and bath immersion administration.
Evans JJ; Klesius PH; Shoemaker CA
Vaccine; 2004 Sep; 22(27-28):3769-73. PubMed ID: 15315858
[TBL] [Abstract][Full Text] [Related]
14. Vaccine-induced antibody level as the parameter of the influence of environmental salinity on vaccine efficacy in Nile tilapia.
Wang J; He RZ; Lu GL; Luo HL; Lu DQ; Li AX
Fish Shellfish Immunol; 2018 Nov; 82():522-530. PubMed ID: 30118846
[TBL] [Abstract][Full Text] [Related]
15. GapA, a potential vaccine candidate antigen against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus).
Zhang Z; Yu A; Lan J; Zhang H; Hu M; Cheng J; Zhao L; Lin L; Wei S
Fish Shellfish Immunol; 2017 Apr; 63():255-260. PubMed ID: 28219739
[TBL] [Abstract][Full Text] [Related]
16. Development of attenuated erythromycin-resistant Streptococcus agalactiae vaccine for tilapia (Oreochromis niloticus) culture.
Liu L; Lu DQ; Xu J; Luo HL; Li AX
J Fish Dis; 2019 May; 42(5):693-701. PubMed ID: 30893488
[TBL] [Abstract][Full Text] [Related]
17. Development of live attenuated Streptococcus agalactiae vaccine for tilapia via continuous passage in vitro.
Li LP; Wang R; Liang WW; Huang T; Huang Y; Luo FG; Lei AY; Chen M; Gan X
Fish Shellfish Immunol; 2015 Aug; 45(2):955-63. PubMed ID: 26087276
[TBL] [Abstract][Full Text] [Related]
18. The effect of intermittent hypoxia under different temperature on the immunomodulation in Streptococcus agalactiae vaccinated Nile tilapia (Oreochromis niloticus).
Wang J; Lu DQ; Jiang B; Luo HL; Lu GL; Li AX
Fish Shellfish Immunol; 2018 Aug; 79():181-192. PubMed ID: 29684601
[TBL] [Abstract][Full Text] [Related]
19. Economic appraisal of vaccination against Streptoccocus agalactiae in Nile tilapia farms in Brazil.
Delphino MKVC; Barone RSC; Leal CAG; Figueiredo HCP; Gardner IA; Gonçalves VSP
Prev Vet Med; 2019 Jan; 162():131-135. PubMed ID: 30621892
[TBL] [Abstract][Full Text] [Related]
20. Major surfome and secretome profile of Streptococcus agalactiae from Nile tilapia (Oreochromis niloticus): Insight into vaccine development.
Li W; Wang HQ; He RZ; Li YW; Su YL; Li AX
Fish Shellfish Immunol; 2016 Aug; 55():737-46. PubMed ID: 27327442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
